Evercore ISI Increases Procter & Gamble (NYSE:PG) Price Target to $183.00

Procter & Gamble (NYSE:PG) had its price objective increased by stock analysts at Evercore ISI from $180.00 to $183.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s price target would indicate a potential upside of 7.82% from the stock’s current price.

A number of other research firms also recently weighed in on PG. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research report on Thursday, August 29th. BNP Paribas assumed coverage on shares of Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. DA Davidson lifted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a report on Monday. Finally, Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Procter & Gamble Trading Up 0.1 %

Shares of PG stock opened at $169.73 on Monday. The company has a market cap of $400.59 billion, a P/E ratio of 29.26, a PEG ratio of 3.72 and a beta of 0.41. Procter & Gamble has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The stock has a 50 day simple moving average of $171.87 and a two-hundred day simple moving average of $167.43.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the firm earned $1.83 earnings per share. Procter & Gamble’s revenue was down .6% on a year-over-year basis. Research analysts forecast that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock worth $65,140,718 in the last quarter. Insiders own 0.18% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Institutional investors have recently made changes to their positions in the stock. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the 2nd quarter worth about $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth approximately $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.